Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.695 USD | +1.32% | +7.57% | -33.99% |
May. 13 | Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating | MT |
May. 10 | Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.99% | 353M | |
+48.69% | 56.95B | |
+39.98% | 40.26B | |
-7.07% | 39.32B | |
-4.42% | 28.37B | |
+12.37% | 26.45B | |
-17.98% | 19.41B | |
+29.22% | 12.54B | |
+25.94% | 12.21B | |
-0.26% | 12.15B |
- Stock Market
- Equities
- ORGO Stock
- News Organogenesis Holdings Inc.
- Transcript : Organogenesis Holdings Inc., Q2 2021 Earnings Call, Aug 09, 2021